Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (NY: ALUR ) 0.6600 -0.0145 (-2.15%) Official Closing Price Updated: 7:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about ALUR < Previous 1 2 Next > Allurion Receives Continued Listing Standards Notice from NYSE August 15, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update August 13, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024 July 16, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement June 28, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Announces Launch of Offering of Common Stock and Warrants June 26, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss June 20, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery June 11, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer June 05, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s May 30, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion to Participate in Two Upcoming Investor Conferences in June 2024 May 29, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss May 15, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Reports First Quarter 2024 Financial Results and Provides Business Update May 14, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey May 02, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Announces Preliminary First Quarter 2024 Results April 30, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments April 17, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Expands Virtual Care Suite to the United States April 04, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance March 21, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference March 13, 2024 From Allurion Technologies, Inc. Via Business Wire Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair March 12, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024 March 04, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion to Participate in Cowen’s 44th Annual Health Care Conference February 20, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference February 08, 2024 From Allurion Technologies, Inc. Via Business Wire Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies January 29, 2024 From Allurion Technologies, Inc. Via Business Wire Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss January 23, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships January 17, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities January 11, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook January 08, 2024 From Allurion Technologies, Inc. Via Business Wire New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program January 05, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion’s Digital Platform Gains Traction with Expanded Strategic Partnership January 02, 2024 From Allurion Technologies, Inc. Via Business Wire Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update November 13, 2023 From Allurion Technologies, Inc. Via Business Wire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.